ChinaAMC Choice Fund - ChinaAMC Franklin FTSE Innovative Drugs ETF
ChinaAMC Choice Fund - ChinaAMC Franklin FTSE Innovative Drugs ETF (HK:3525) Price & Chart
HK:3525 ETF Chart & Stats
- Day’s Range
- HKD 9.56 - HKD 9.60
- 52-Week Range
- HKD 9.09 - HKD 10.52
- Previous Close
- HKD 9.74
- Volume
- 800
- Average Volume (3M)
- 21.27K
- AUM
- N/A
- NAV
- N/A
- Expense Ratio
- N/A
- Holdings Count
- 0
- Beta
- 0.29
- Inception Date
- Sep 29, 2026
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 63,500,000
- Standard Deviation
- N/A
ETF Overview
ChinaAMC Choice Fund - ChinaAMC Franklin FTSE Innovative Drugs ETF
ChinaAMC Choice Fund – ChinaAMC Franklin FTSE Innovative Drugs ETF (HK:3525) is a sector-focused healthcare ETF designed to provide targeted exposure to China’s innovative pharmaceuticals and drug-development companies. The fund seeks to track, before fees and expenses, the performance of the FTSE ETF Connect Innovative Drugs Index (Net Total Return), offering investors a diversified portfolio centered on businesses involved in the research, development, manufacturing, and commercialization of innovative medicines. It provides a focused way to participate in the growth potential of China’s healthcare and biotechnology industries, while remaining subject to the volatility, regulatory developments, competitive pressures, and company-specific risks associated with the innovative-drugs sector. There is no assurance that the fund will achieve its investment objective.
- Asset Class
- Equity
- Region
- Global
- Issuer
- ChinaAMC
- Index Tracked
- FTSE ETF Connect Innovative Drugs Index - HKD - Benchmark TR Net
- Ticker Symbol
- HK:3525
